Prospective validation in 798 postmenopausal women of a new screening tool for osteoporosis risk assessment:: Osiris® (osteoporosis index of risk)

被引：0
|
作者：
Reginster, JY
Viethel, P
Micheletti, MC
Chevallier, T
Audran, M
机构：
[1] WHO, Collaborat Ctr Publ Hlth Aspects Rheumat Dis, Liege, Belgium
[2] Dept Med, Theramex Merck, Monaco
[3] Univ Montpellier, Dept Biostat Epidemiol & Clin Res, Montpellier, France
[4] CHU Angers, Dept Rheumatol, Angers, France
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [31] OSTEOPOROSIS RISK ASSESSMENT TOOLS TO SCREEN POSTMENOPAUSAL WOMEN IN SRI LANKA
    Subasinghe, H.
    Lekamwasam, S.
    Ball, P.
    Morrissey, H.
    Waidyaratne, E. I.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S497 - S497
  • [32] CLINICAL PERFORMANCE OF OSTEOPOROSIS RISK ASSESSMENT TOOLS IN SERBIAN POSTMENOPAUSAL WOMEN
    Nikitovic, M.
    Snezana, P.
    Violeta, C.
    Vasic, J.
    Gojkovic, F.
    Trumbic, S.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 123 - 123
  • [33] Performance of the osteoporosis risk assessment tool (OST) in Russian women
    Lesnyak, Y
    Ershova, O
    Menshikova, L
    Lesnyak, O
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S53 - S53
  • [34] BONE MARKERS IN POSTMENOPAUSAL WOMEN: EVALUATION OF OSTEOPOROSIS RISK INDEX IN WOMEN TREATED WITH DENOSUMAB
    Kocevska, A. K.
    Todorova, B. J. T. Jovanoska
    Nakov, A. N.
    Kocevska, B. K.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S321 - S321
  • [35] Validation of the Gail model for breast cancer risk in postmenopausal women with osteoporosis.
    Goldstein, S.
    Yeo, A.
    Qu, Y.
    Wong, M.
    Mitchell, B.
    Mershon, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S175 - S176
  • [36] THE PERFORMANCE OF OSTEOPOROSIS SELF-ASSESSMENT TOOL FOR ASIANS (OSTA) IN ASSESSING THE RISK OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN AGED 45 YEARS AND OLDER
    Nguyen, N.
    Tran, T.
    Truong, T.
    Truong, T.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S205 - S205
  • [37] Utilization and correlates of osteoporosis treatment in postmenopausal women: Observations from the National Osteoporosis Risk Assessment (NORA).
    Siris, ES
    Miller, PD
    Barrett-Connor, E
    Sajjan, S
    Weiss, TW
    Chen, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S402 - S403
  • [38] Utilization and correlates of osteoporosis treatment in postmenopausal women: Observations from the National Osteoporosis Risk Assessment (NORA).
    Siris, E
    Miller, P
    Barrett-Connor, E
    Sajjan, S
    Weiss, TW
    Chen, YT
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S290 - S291
  • [39] Identifying Younger Postmenopausal Women With Osteoporosis Using USPSTF-Recommended Osteoporosis Risk Assessment Tools
    Zheng, Henry W.
    Bui, Alex A. T.
    Ensrud, Kristine E.
    Wright, Nicole C.
    Manson, JoAnn E.
    Watts, Nelson B.
    Johnson, Karen C.
    Shadyab, Aladdin H.
    Crandall, Carolyn J.
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [40] Prevalence of osteoporosis and prediction of osteoporosis risk in Italian peri- and postmenopausal women: The detection of osteoporosis risk (DOOR) study
    Agnusdei, D
    Calcagno, V
    Christiansen, C
    Crepaldi, G
    Gennari, C
    Martini, L
    Mazzuoli, GF
    Pasquarelli, V
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (02): : 110 - 122
12345